Analyst Price Target is $16.75
▲ +50.63% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $16.75, with a high forecast of $18.00 and a low forecast of $16.00. The average price target represents a 50.63% upside from the last price of $11.12.
Current Consensus is
Buy
The current consensus among 4 investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.